Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_assertion type Assertion NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_head.
- NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_assertion description "[Interestingly, we found that CNI-induced VEGF overexpression and cancer cell proliferation was inhibited by rapamycin treatment, indicating potential involvement of the mammalian target of rapamycin (mTOR) pathway in this tumorigenic process.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_provenance.
- NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_assertion evidence source_evidence_literature NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_provenance.
- NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_assertion SIO_000772 21886838 NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_provenance.
- NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_assertion wasDerivedFrom befree-20150227 NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_provenance.
- NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_assertion wasGeneratedBy ECO_0000203 NP956827.RAAKLY5VduSwLIV0zoelf8MxQHOJ4t-DuEwwMzO4Cf8ZE130_provenance.